USPTO serial 79354042
SINTETOL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 6, 2024
- Examiner
- FLETCHER, TRACY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SINTETOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of respiratory system disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases, pain, cancer and tumors; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; vaccines; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of infectious diseases, pain, cancer and tumors; diagnostic preparations for medical purposes; absorbent wadding for medical purposes | ACTIVE | — |
| 035 | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, except dietary supplements; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies, except dietary supplements; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies, except dietary supplements; retail and wholesale store services featuring pharmaceutical preparations, except dietary supplements; marketing services; commercial administration of the licensing of the goods and services of others; providing television home shopping services in the field of general consumer merchandise; advertising services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named SINTETOL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 24, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 11, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 6, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 6, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 1, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 1, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 19, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 12, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 4, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 3, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |